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Case Report
Surgical Treatment for Biliary Carcinoma
Arising After Pancreatoduodenectomy
HITOSHI SEKI a, SHINICHI MIYAGAWAa’*, AKIRA KOBAYASHI
and SEIJI KAWASAKI
First Department of Surgery, Shinshu University, School of Medicine, Matsumoto, Japan
(Received 28 November 1996)
The clinicopathological features and surgical treat-
ment of biliary carcinoma around the major hepatic
duct confluence arising after pancreatoduodenecto-
my (PD) due to initial bile duct carcinoma are
described in three patients. Occurrence of biliary
carcinoma more than 12 years after initial surgery
and a histological finding of cholangiocellular
carcinoma mixed with hepatocellular carcinoma
suggested metachronous incidence of biliary carci-
noma after PD. Extended right hemihepatectomy
with complete removal of the residual extrahepatic
bile duct and segmental,resection of the jejunal loop
were carried out safely without operative death or
severe postoperative complications. Two patients
died of tumor recurrence 6 months after surgery,
and the remaining patient is currently living a
normal life without evidence of recurrence 17
months after surgery. These surgical procedures
are a therapeutic option in patients with biliary
carcinoma around the major hepatic duct confluence
arising after PD.
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nectomy, surgical treatment, metachronous incidence
INTRODUCTION
Surgical treatment for biliary carcinoma arising
around the major hepatic duct confluence in
patients who had undergone pancreatoduode-
nectomy (PD) due to initial bile duct carcinoma
has been reported only rarely [1]. This article
describes three patients with biliary carcinoma
arising after PD, and discusses their clinico-
pathological characteristics and surgical treat-
ment.
PATIENT PROFILE
In the three patients in whom PD had been
performed due to initial bile duct carcinoma,
complete removal of the main tumor including
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the regional lymph nodes had been achieved.
They had suffered several episodes of acute
cholangitis and/or obstructive jaundice before
admission. Direct cholangiography revealed
strictures in the residual biliary tree. In these
three patients, the time from initial surgery to
presentation with further tumor was 50, 70 and
153 months, respectively. Preoperative imaging
examinations showed biliary carcinoma extend-
ing from the hepaticojejunal anastomosis to both
the right and left hepatic ducts. Therefore
residual extrahepatic bile duct resection with
concomitant hepatectomy was chosen. A meta-
static liver tumor located in segment 3 and
residual gastric cancer were also detected in one
of the patients (No. 2) (Tab. I).
RESULTS
Operation time and operative blood loss are
shown in Table I. Postoperatively, an abdominal
abscess developed in one patient (No. 2), but this
was treated successfully without re-laparotomy.
Histological examination of the resected speci-
mens showed cholangiocarcinoma in two pa-
tients and cholangiocellular carcinoma mixed
with hepatocellular carcinoma in the other
(No.l). One patient (No. 2) had a surgical
margin microscopically positive for carcinoma
at the left hepatic duct due to subepithelial
spread of the carcinoma. Metastasis to the lymph
nodes in the jejunal loop, which had been
arised for hepaticojejunostomy, was detected in
one patient (No. 3). There was no operative or
hospital mortality. Two patients (Nos. 1 and 2)
died of tumor recurrence 6 months after
surgery, and the remaining patient (No. 3) is
currently living a normal life without evidence
of recurrence 17 months after surgery.
DISCUSSION
Few reports have described metachronous car-
cinoma in the biliary tree. Among the present
three patients, occurrence of metachronous
biliary carcinoma was strongly suspected in
two, because one (No. 1) had cholangiocellular
carcinoma mixed with hepatocellular carcinoma,
which was histologically different from the
initial tumor, and the other (No. 2) had biliary
carcinoma arising more than 12 years after
removal of the initial malignancy. In the remain-
ing patient (No. 3), the possibility of very slow
recurrence of the primary lesion could not be
ruled out in view of the histological features of
the first and second resected specimens, even
though more than five years had passed since
the initial operation.
Surgical resection is the only curative treat-
ment for biliary carcinoma [2]. The role of
repeated resection for treatment of biliary
carcinoma arising after PD is not well docu-
mented [1, 3]. In most patients with biliary
carcinoma arising after PD, previous surgery
TABLE Characteristics of the three patients with metachronous biliary carcinoma
No. Age Sex Histology Second ca. Time Op. Op.T Op. B Histology of Outcome
of initial ca. location (M) (min) (ml) second ca.
75 M Tub. RHD to IHBD 50 ERH 650 910 CCC+HCC D (6 M)
2 68 M Pap-tub Biliary con. 153 ERH+c 1065 2460 Pap-tub. D (6 M)
3 69 F Pap-tub. Biliary con. 70 ERH 700 738 Pap. A (17 M)
No., number of patient; Ca. carcinoma; Time (M), time from initial surgery to presentation with further tumor (months); Op, operative procedure;
Op.T. (min), operation time (minutes); Op. B. (ml), operative blood loss (ml); RHD, right hepatic duct; IHBD, intrahepatic bile duct; ERH,
extended right hemihepatectomy; Biliary con., major biliary confluence; Tub., tubular adenocarcinoma; Pap-tub., papillo-tubular adenocarci-
noma; Pap., papillary adenocarcinoma; c, partial gastrectomy and limited resection of segment 3 due to a metastatic liver tumor; CCC,
cholangiocellular carcinoma; HCC, hepatocellular carcinoma; D (6 M), died at 6 months; A (17 M), disease-free at 17 months.SURGICAL TREATMENT FOR BILIARY CARCINOMA 397
and the spread of the tumor preclude re-
resection, and instead percutaneous external
drainage is chosen. Analysis of several large
series published in recent years does not provide
information on the feasibility of repeated resec-
tion [1]. Radical extended resection, such as
extended right hemihepatectomy, for carcinoma
of the biliary confluence gives better survival
figures than local resection [4, 5].
In the present three patients, concomitant
extended right hemihepatectomy was chosen
because the extrahepatic biliary carcinoma was
located around the major hepatic duct confluence
in two patients (Nos. 2 and 3), and the cancer
arose from the intrahepatic bile duct and ex-
tended to the major hepatic duct confluence in the
other patient (No. 1). The operations were carried
out safely, and one patient (No. 3) is now enjoying
a normal life without recurrence more than 17
months after surgery. Complete removal of the
residual extrahepatic bile duct and segmental
resection of the jejunal loop with concomitant
major hepatectomy is a therapeutic option in
patients with biliary carcinoma around the major
hepatic duct confluence arising after PD.
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COMMENTARY
The above manuscript describes an aggressive
approach (extended right hepatectomy) for
recurrent cholangiocarcinoma following pan-
creaticoduodenopathy. It is always attractive
for surgeons to consider long-term survivors
following primary surgery for repeated surgical
resections. Those patients considered for repeat
resection had survival ranging from 50 to 153
months following the initial resection. These
patients have probably selected themselves due
to the relative benign course of their post-
operative survival.
Repeat resection can be very difficult and may
necessitate vascular reconstruction. In this series
the operative time ranged from 11 to 17 hours.
The authors are to be congratulated on their
results as there was no operative or hospital
mortality and minimal morbidity.
Unfortunately, two patients died after 6
months. However, the third patient profitted
from repeated resection with 17 months survival
without recurrence. It is not clear at this stage,
how the patients most suitable for resection
were selected. It is also not clear from this study
why the third patient survived and the other
died within a short period of the recurrence.
Studies of tumour biology such as the pre-
sence of gene mutation and genomic instability
may enable the HPB surgeon to select those
patients with less aggressive phenotype that
might benefit from aggressive surgery.
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